RAPS develops and provides solutions in flavoring, using their expertise in ingredients and technology for the food industry, food service, and retail butchery sector.

RAPS Spices

RAPS Spices focuses on providing flavor solutions to customers in the food industry, food service, and retail butchery sector, utilizing their knowledge of ingredients and technology to ensure high quality products.

Professional Training and Coaching

RAPS Europe

Regulatory Affairs Certification Program

Industry Associations

RAPS UK Local Networking Group

RAPS Ontario Chapter

RAPS Quebec Local Networking Group

Medical Equipment Manufacturing

RAPS Western Canada Chapter

RAPS Belgium Local Networking Group

RAPS Twin Cities Chapter

RAPS Ireland Local Networking Group

RAPS Boston Chapter

RAPS Nordic Local Networking Group

RAPS New York/New Jersey Chapter

RAPS Chicago Chapter

RAPS Utah Chapter

RAPS Brazil Local Networking Group

RAPS Portugal Local Networking Group

Non-profit Organizations

RAPS Atlanta Chapter

RAPS Italy Local Networking Group

RAPS Philadelphia Chapter

RAPS France Local Networking Group

RAPS Northeast Asia Local Networking Group

RAPS Southern California Local Networking Group

RAPS Wisconsin Chapter

RAPS DC/Baltimore Chapter

RAPS Netherlands Chapter

RAPS Spain Local Networking Group

RAPS Indiana Chapter

RAPS Florida Chapter

RAPS Germany Chapter

RAPS India Local Networking Group

RAPS Texas Chapter

RAPS Colorado Chapter

RAPS ASEAN Local Networking Group

RAPS Ohio Local Networking Group

RAPS MENA Local Networking Group

RAPS Israel Local Networking Group

RAPS Michigan Local Networking Group

RAPS New Zealand Local Networking Group

Regulatory Affairs Professionals Society (RAPS) | 177,606 followers on LinkedIn. Driving Regulatory Excellence | The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence.

Certification, Competency Profiling, and Learning Leader

Jennifer Naughton

Bill McMoil

Web Application Developer

Ravi G.

Michelle Ragozzino, Ph.D., RAC-Devices

Regulatory Affairs Professionals Society (RAPS)

Do you look forward to running into your organization's executives in the hallway or to accepting their invitation to meet about your latest idea? These are pivotal opportunities for regulatory professionals at any career stage. Are you prepared to make the most of them? Effectively communicating with executives is not just a professional advantage, it's a career accelerator. In this high-energy, interactive virtual program, speakers Nancy Singer and Robin Crawford, will teach you how to prepare for interactions with the C-suite. Gain tools to describe an issue in 30 seconds using the “What”, “So What”, “Now What” pattern, and much more. This workshop is part of the RAPS Certificate in Effective Communication. Complete all five workshops to get an education in the key elements of regulatory communication. Sign up today: https://bit.ly/3XxiLxJ

The changes discussed by President-elect Trump and his supporters during and after the election could fundamentally change the way FDA operates, experts said in interviews with Focus. Ferdous Al-Faruque reports in Regulatory Focus https://bit.ly/4epYwbI

After a highly successful inaugural event in 2024, DIA and RAPS will reconvene the jointly produced summit, Combination Products in the EU. Gather your team and make plans to join us and DIA on 28-29 January 2025 at the Radisson Grand Place in Brussels, Belgium. Get ready to interact with key stakeholders across the field—including representatives from EMA, the European Commission, Notified Bodies, National Competent Authorities and Industry—to explore a coordinated drug and device approach to incentivize competitive innovation in Europe. This year's event will focus on addressing challenges, creating efficiencies, engaging with experts and exchanging ideas. Save your seat today: https://bit.ly/4gHYJt1

Every new career journey begins with a first step. You're invited to hear valuable insights directly from a Kellogg Executive Education team member. Learn how this unique leadership opportunity could significantly change your career trajectory in 2025. Sign up for this Q&A to get your questions answered and to hear first-hand about this popular regulatory-dedicated leadership program. Reserve your spot today: https://bit.ly/4hADs51

Companies in India, China, and Europe continue to play an outsized role in manufacturing active pharmaceutical ingredients (API) used in products destined for the US market in terms of locations cited in API drug master files filed with FDA. Joanne Eglovitch reports in Regulatory Focus 📢 https://bit.ly/4hGHLf8

Earlier in 2024, we hosted the RAPS Regulatory Intelligence Conference and the RAPS Global Regulatory Strategy Conference for the first time. We are so excited to be bringing them back in 2025! This time, we will be hosting these conferences back-to-back in the same location: Baltimore, Maryland. We invite you to join us for a few days, or for the whole week! (If you register for both conferences, you get a discount.) Learn more here: https://bit.ly/3O0zchm

FDA announced on Thursday plans to remove oral phenylephrine from the over-the-counter monograph for nasal decongestants following an “extensive review” which found that the ingredient is ineffective. Joanne Eglovitch reports in Regulatory Focus 📝 📣 https://bit.ly/4ehlnWM

The Outsourcing Facilities Association has called for more transparency in FDA's inspections and in the development of the 503B bulk drug substances list, which lists drugs substances for which there is or isn’t a clinical need for compounding. The Pharmaceutical Research and Manufacturers of America, on the other hand, urged greater FDA oversight of compounding by outsourcing facilities. Joanne Eglovitch reports in Regulatory Focus ✍️ 📢 https://bit.ly/48CaT2Z

The European Commission has published a question-and-answer document explaining the responsibilities manufacturers have to alert stakeholders about potential shortages under amendments to the MDR and IVDR. The paper details the timelines manufacturers should follow and who they must notify. Ferdous Al-Faruque reports for Regulatory Focus: https://bit.ly/3YA4Pnc

Inefficient meetings are a top pet peeve of regulatory professionals. Wouldn't it be great to use them to actually get work done? In this high-energy, interactive virtual program, speakers Nancy Singer and Robin Crawford will show you how to make meetings work for you — instead of the other way around. Plus, you'll learn 10 practical techniques that will help you avoid common missteps, communicate succinctly, and help you convince your coworkers to pursue your desired course of action. This workshop is part of the RAPS Certificate in Effective Communication. Complete all five workshops to get an education in the key elements of regulatory communication — a certificate to prove it. Sign up today: https://bit.ly/3YAGCgw

RAPS

COM:RAPS

RAPS Spices